Back to news archive
Image for Gradientech announces appointment of new Board of directors
News 2023-05-16

Gradientech announces appointment of new Board of directors

Gradientech is proud to announce the appointment of two new members to the Gradientech Board of Directors; Dr Hilja Ibert and Dr Nedal Safwat.

Dr Hilja Ibert is currently CEO of Gentian Diagnostics and brings more than 30 years of experience from the clinical diagnostics industry at international companies like Hologic, Becton Dickinson and bioMérieux, including Vice President and General Manager positions within the business areas of Diagnostic systems and Bioscience.

Dr Nedal Safwat is currently the Vice President and Head of Molecular Diagnostics North America at Qiagen. Previous to his current position, Dr Nedal Safwat brings more than 15 years of experience from the clinical diagnostics industry, specifically with business unit and commercial roles at bioMérieux covering microbiology applications including bacteria identification, antibiotic susceptibility testing, antibiotic resistance, and sepsis detection products.

Link to press-release

Gradientech is an ISO13485 certified company since 2017


Gradientech AB
Uppsala Science Park
SE-751 83 Uppsala

About Gradientech

Gradientech develops, manufactures and sells innovative microfluidic products for high-quality analysis of the behavior of cells and organisms in response to gradients of biomolecules. Our aim is to pioneer life science and healthcare.

Copyright © 2023 Gradientech. All rights reserved. Gradientech, QuickMIC and CellDirector are registered trademarks or trademarks of Gradientech AB.

Next-generation antimicrobial susceptibility testing

Take a look at our E-book